Paul Lammers's most recent trade in Decoy Therapeutics Inc. was a trade of 2,000 Common Stock done . Disclosure was reported to the exchange on Aug. 31, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Decoy Therapeutics Inc | Paul Lammers | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Aug 2026 | 2,000 | 2,001 (0%) | 0% | 0 | Common Stock | |
| Decoy Therapeutics Inc | Lammers Paul | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2024 | 20,500 | 20,500 | - | - | Stock Option (right to buy) | |
| Decoy Therapeutics Inc | Paul Lammers | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2023 | 1,440 | 1,718 (0%) | 0% | 0 | Common Stock | |
| Decoy Therapeutics Inc | Paul Lammers | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2022 | 30,000 | 30,000 | - | - | Stock Option (right to buy) |